FindTrial
Sign In

A Split-face, Randomized,controlled Trial Comparing Efficacy of 2940 nanometer Erbium YAG laser Combined with Triple Combination Cream Versus the Cream Alone for the Treatment of Melasma in Asians

A Split-face, Randomized,controlled Trial Comparing Efficacy of 2940 nanometer Erbium YAG laser Combined with Triple Combination Cream Versus the Cream Alone for the Treatment of Melasma in Asians

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180814006
Enrollment
20
Registered
2018-08-14
Start date
2012-12-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melasma

Interventions

2940 nanometer Erbium YAG laser Combined with Triple Combination Cream,2940 nanometer Erbium YAG laser
Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery

Sponsors

Dermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital
Lead Sponsor
Dermatology division&#44
Collaborator
Department of internal medicine&#44
Collaborator
King Chulalongkorn Memorial Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with melasma

Exclusion criteria

Exclusion criteria: -pregnancy -allergic to Hydroquinone

Design outcomes

Primary

MeasureTime frame
melasma 0,4,8,12 weeks Photograph—

Secondary

MeasureTime frame
skin color 0,4,8,12 weeks Photograph—

Countries

Thailand

Contacts

Public ContactRatchathorn Panchaprateep

Faculty of Medicine, Chulalongkorn University

rpanchaprateep@gmail.com0898923819

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026